Back to Search
CHERYL WILLMAN, MD
MD
Clinical Pathology/Laboratory Medicine Physician
NPI: 1124035175Individual
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
85-126(TX)
Research & Publications (20)
Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
PMID 18342809·Best Pract Res Clin Haematol·2008
8-other
Discovery of novel molecular classification schemes and genes predictive of outcome in leukemia.
PMID 15190296·Hematol J·2004
6-review
Targeted AML therapy: new biologic paradigms and therapeutic opportunities.
PMID 11368384·Leukemia·2001
6-review
JAK mutations in high-risk childhood acute lymphoblastic leukemia.
PMID 19470474·Proc Natl Acad Sci U S A·2009
8-other
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
PMID 18927435·Blood·2009
8-other
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
PMID 19129520·N Engl J Med·2009
8-other
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
PMID 19176441·JAMA·2009
8-other
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.
PMID 18768390·Blood·2008
8-other
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.
PMID 18182569·Blood·2008
8-other
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
PMID 18388178·Blood·2008
8-other
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].
PMID 18802149·J Clin Oncol·2008
4-observational
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.
PMID 18422996·Br J Haematol·2008
8-other
Regularization strategies for hyperplane classifiers: application to cancer classification with gene expression data.
PMID 17477492·J Bioinform Comput Biol·2007
7-preclinical
Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia.
PMID 17410195·Leukemia·2007
8-other
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
PMID 17696203·Am J Hematol·2007
3-trial
Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia.
PMID 17170128·Blood·2007
8-other
Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials.
PMID 17197435·Blood·2007
3-trial
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia.
PMID 16368883·Blood·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2325 CAMINO DE SALUD NE, UNM CANCER RESEARCH - TREATMENT CENTER
ALBUQUERQUE, TX 87131 - Phone
- (505) 272-5622
Quick Facts
- NPI
- 1124035175
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile